http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1464709-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7a5389a45a98fa3b41048c16b073b9e3 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-112 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-154 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-708 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-70 |
| filingDate | 2003-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2007-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_358e9fb71e46a7b611c2a2768f59e292 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_380017b278d29e317bec1bac6cf6d735 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ab39b1b927d556fd4f4275b710940ec |
| publicationDate | 2007-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-1464709-B1 |
| titleOfInvention | Detection of HPV-induced invasive cancers and their precursor lesions with invasive potential |
| abstract | The invention is in the field of medicine and is concerned with a molecular diagnostic marker for HPV-induced invasive cancers and their precursor lesions with invasive potential. In particular the present invention relates to the use of the TSLC1 gene as marker for invasive cervical cancer. The invention provides methods for detecting HPV-induced invasive cancers and their precursor lesions associated with tumor suppressor lung cancer 1 (TSLC1), comprising contacting a target cellular component of a test cell with a reagent that detects TSLC1 and detecting a reduction in the TSLC1 as compared to that of a comparable normal cell. The invention also provides molecular diagnostic markers for premalignant cervical lesions with invasive potential associated with tumor suppressor lung cancer 1 (TSLC1) in cytologically abnormal cervical smears and/or biopsies. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101769160-B1 |
| priorityDate | 2003-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 66.